Viewpoint: Reflections on an Analysis of Health Canada’s NOC/c Policy for Oncology Drug Approvals Melissa Kampman, Melissa Hunt, Kelly Robinson, Health Canada Published May 31, 2024 PDF HTML
Viewpoint: Bayesian Hierarchical Models of Basket Trials in the Context of Economic Evaluation Karen M. Lee Published May 31, 2024 PDF HTML
Oncology Drug Approvals Under Health Canada’s Notice of Compliance With Conditions Policy: A Retrospective Cohort Analysis Anna Martin, Melissa Hunt, Scott Blommaert, Suji Udayakumar, Brandon Lu, Shreya Chatterjee, Gaaya Sathiyabalan, Jan Brun, Melissa Kampman, Laurie Lambert, Nicole Mittmann, Kelly Robinson, Kevin KW Chan Published May 31, 2024 PDF HTML
Bayesian Hierarchical Models of Basket Trials in the Context of Economic Evaluation CADTH Published May 31, 2024 PDF HTML
Alemtuzumab, Cladribine, Fingolimod, Natalizumab, and Rituximab as First-Line Treatments in Adults With Highly Active Relapsing-Remitting Multiple Sclerosis CADTH Published May 30, 2024 PDF HTML
Biologic Drugs for Severe Asthma Jason R. Randall, Richard Leigh, Ellen T. Crumley, Sylvia Aponte-Hao, Ngoc Khanh Vu, Karen Martins, Scott Klarenbach Published May 1, 2024 PDF HTML
Anticytokine Therapy and Corticosteroids for Cytokine Release Syndrome and for Neurotoxicity Following T-Cell Engager or CAR T-Cell Therapy CADTH Published May 2, 2024 PDF HTML
